Home Latin News Dexamethasone, solely therapeutic efficient towards Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient towards Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient towards Covid-19, WHO chief states — Autopresse.eu

Dexamethasone, solely therapeutic efficient towards Covid-19, WHO chief states — Autopresse.eu

2020-10-17 09:42:00

Dexamethasone, solely therapeutic efficient towards Covid-19, WHO chief states

Saturday, October seventeenth 2020 – 09:42 UTC


“For the second, the corticosteroid dexamethasone remains to be the one therapeutic proven to be efficient towards COVID-19, for sufferers with extreme illness,” Tedros.

Presently, the drug dexamethasone remains to be the one therapeutic proven to be efficient towards the novel coronavirus for extreme sufferers, the chief of the World Well being Group stated Friday.

Presently, the drug dexamethasone remains to be the one therapeutic proven to be efficient towards the novel coronavirus for extreme sufferers, the chief of the World Well being Group stated Friday.

WHO Director-Normal Tedros Ghebreyesus addressed journalists at a twice-weekly webinar from Geneva on the battle towards the pandemic.

He revealed interim outcomes from the WHO’s Solidarity Therapeutics Trial and referred to influenza, which will be countered utilizing a few of the similar strategies as these used towards COVID-19.

Tedros additionally cautioned that demand for influenza vaccines would possibly outstrip provide in some nations, significantly within the northern hemisphere, as Winter arrives.

“The Strategic Advisory Group of Consultants on Immunization has due to this fact beneficial that, among the many 5 threat teams, well being employees and older adults are the best precedence teams for influenza vaccination throughout the COVID-19 pandemic,” he stated.

“Yearly, there are as much as 3.5 million extreme circumstances of seasonal influenza worldwide, and as much as 650,000 respiratory-related deaths.”

Throughout this 12 months’s southern hemisphere winter, the variety of seasonal flu circumstances and deaths was lower than common as a result of measures taken to comprise COVID-19.

“However, we can not assume the identical can be true within the northern hemisphere flu season,” stated the WHO chief.

Turning to the Solidarity Therapeutics Trial, Tedros stated it confirmed that two different medicine, remdesivir and interferon, have little or no impact on stopping coronavirus-related deaths or lowering time within the hospital.

“For the second, the corticosteroid dexamethasone remains to be the one therapeutic proven to be efficient towards COVID-19, for sufferers with extreme illness,” stated Tedros.

Dexamerhasone is used within the remedy of many situations, together with rheumatic subject, numerous pores and skin situations, extreme allergy symptoms, bronchial asthma, power obstructive lung illness, croup, mind swelling and eye ache following eye surgical procedure. Additionally it is used with antibiotics in circumstances of tuberculosis.

The COVID-19 pandemic has claimed greater than 1.1 million lives in 188 nations and areas since final December. The US, India, Brazil, and Russia are presently the worst-hit nations.

Greater than 39 million circumstances have been reported worldwide, whereas practically 27 million sufferers have recovered, in accordance with figures compiled by the US’ Johns Hopkins College.

Leave a Reply

Your email address will not be published.